This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Articles

Foreword Global Research in Anxiety and Depression (GRAD) Network Consensus Conference

Martin B. Keller, MD

Published: August 1, 2002

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Although awareness of anxiety and depressive disorders is increasing among thegeneral population, patients often fail to consult their physician for their illness.Even when patients do seek medical help, anxiety and depressive disorders are frequentlyunderrecognized, underdiagnosed, and undertreated. Recent advances in ourunderstanding of the chronic course of both anxiety and depressive disorders indicatethat patients should be treated with antidepressants at an appropriate dosage and for asufficient duration to maximize the chance of remission of their illness.’ ‹


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 63

Quick Links: Anxiety , Anxiolytics

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...

Read More...